Curaleaf Announces Closing of C$520 Million Offering and Begins Trading on the CSE Under Ticker Symbol "CURA"

Published: October 29, 2018

Curaleaf Announces Closing of C$520 Million Offering and Begins Trading on the CSE Under Ticker Symbol

Curaleaf Holdings, Inc., a leading vertically integrated cannabis operator in the U.S., began trading on the Canadian Securities Exchange (“CSE”) under the ticker symbol “CURA”.

In connection with the listing, Curaleaf raised approximately C$520 million (US$400 million) in an oversubscribed private placement offering led by GMP Securities L.P. and Canaccord Genuity Corp., on behalf of a syndicate of agents, including Cormark Securities Inc., Eight Capital and Haywood Securities Inc. This offering marks the largest cannabis equity financing completed to date.

“Listing on the Canadian Securities Exchange is a critical step in our growth trajectory. We are excited to make our mark within cannabis financing history through the overwhelming support of over 100 institutions internationally,” said Joseph Lusardi, CEO of Curaleaf. “We remain committed to growing our business through aggressive organic growth and the strategic deployment of capital into accretive acquisitions that extend our brand into the most attractive U.S. markets.”

Curaleaf has a footprint that spans 12 U.S. states, comprising 28 dispensaries, 12 cultivation facilities and 9 processing sites. The Company, including subsidiaries and managed entities, operates in Arizona, Connecticut, Florida, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York and Oregon, with licensing pending in California and Pennsylvania. Through its team of physicians, pharmacists, medical experts and industry visionaries, the Company has developed the Curaleaf brand, a premium mainstream cannabis brand available in multiple states and product formats through its network of branded retail dispensaries.